The website of the Clinical Services Journal

CJ Medical Presents Stretta® Therapy at the British Society of Gastroenterology 2017

Specialising in surgical and medical devices, CJ Medical is committed to facilitating and promoting innovative technologies supported by professional education.

Technologies represented by CJ Medical are used by Physicians in complex surgical procedures to reduce inpatient stay, improve quality of life and healthcare outcomes for patients and hospitals. CJ Medical is the UK Exclusive Distributor of Stretta® Therapy.

Stretta® Therapy

The Stretta® procedure is a safe and effective treatment option for patients who suffer with Gastro-Oesophageal Reflux Disease (GORD) and wish to consider an alternative to medication or surgery for acid reflux.

The innovative Stretta® system delivers low power, low temperature radiofrequency (RF) energy to the Lower Oesophageal Sphincter (LOS) muscle and gastric cardia, which remodels the tissue, resulting in improved barrier function and fewer random relaxations that cause GORD symptoms.

Stretta® Therapy Published in The Parliamentary Review - Highlighting Best practice

Innovative treatment

Mr Viswanath YKS performed the first STRETTA (for acid reflux patients), minimally invasive endoscopic procedure for the treatment of gastro-oesophageal reflux disease first time in NHS in the UK, at James Cook University Hospital, Middlesbrough, in 2014 after undergoing advanced training in France and the USA.

STRETTA (MEDERI Therapeutics & CJ Medical UK) is an outpatient endoscopic day procedure and known to strengthen the lower oesophageal sphincter, that gets weakened in acid reflux patients. He is now also carrying out this procedure for private patients at Nuffield Tees.

In an early study by Mr Viswanath and his team, it was found STRETTA is feasible and safe in the treatment of acid reflux disease in selected patients. It achieved symptomatic relief in the majority of patients and, in patients with poor response to medical therapy, it can be considered as an alternative to surgery.

This procedure is offered within the NHS while also being available at Nuffield Tees for privately-funded patients. While NHS-private collaboration may not be suitable for every patient and every procedure, there are many for which it provides better outcomes for the patient, for the private sector and for the NHS.

Stretta Clinical Highlights

More than 40 studies show that Stretta is safe and effective, with durability of treatment effect up to 10 years.

Stretta treatment has been widely studied:

  • More than 20,000 Stretta procedures performed 

  • 40 clinical studies conclude Stretta safe and effective 

  • Low complication rate <1% (similar to EGD) 

  • 93% patient satisfaction after Stretta 


Long-term data:

  • 4-year follow-up 86% of patients off daily PPIs 

  • 8-year follow-up 72% of patients off daily PPIs 

  • 10-year follow-up 64% of patients off PPIs

The new Meta-Analysis of 28 Studies Shows Stretta® Therapy for GORD Consistently and Significantly Improves Outcomes, with the following results:

  • Significant improvement in health-related quality of life
  • Significant reduction in heartburn symptoms
  • The majority of patients off proton pump inhibitors (PPIs)
  • Significant healing of erosive oesophagitis
  • Significant reduction in oesophageal acid exposure
  • Low adverse event rate of <1%

Recently published health economic data demonstrate that treating GORD with Stretta results in significant cost savings to payers, compared to long-term medications or surgery.

The NICE Stretta® Publication, Medtech Innovation Briefing (MIB), recognised the innovative aspects of Stretta® as the only RF energy device for the treatment of Gastric Reflux.

The Stretta Centre – Patient Referral Portal

A dedicated patient information portal, the Stretta Centre, is available to patients which offers Private and NHS Patient Referrals, Dedicated Patient Coordinator and Live Patient Support Phone Line. To view the website, please visit: www.strettacentre.com  

We look forward to meeting you at our exhibition stand no. 41. If you would like to get in touch, please emails us at office@cjmedical.com  

T: 020 3198 2420    F: 020 3198 2421


More information on the company’s products and services can be found at: www.cjmedical.com
  Follow us on Twitter: @cjmedicaluk

See more about CJ Medical

Upcoming Events

World Hand Hygiene Day

Worldwide
5th May 2024

Theatres & Decontamination Conference 2024

Coventry Building Society Arena
16th May 2024

The AfPP Roadshow - Birmingham

Millennium Point, Birmingham
18th May 2024

BAUN Summer Educational Event – Essential Urology Skills

Crowne Plaza, Newcastle Stephenson Quarter
6th June 2024

The AfPP Roadshow - Exeter

University of Exeter
22nd June 2024

EBME Expo

Coventry Building Society Arena
26th - 27th June 2024

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Upcoming Events

World Hand Hygiene Day

Worldwide
5th May 2024

Theatres & Decontamination Conference 2024

Coventry Building Society Arena
16th May 2024

The AfPP Roadshow - Birmingham

Millennium Point, Birmingham
18th May 2024

BAUN Summer Educational Event – Essential Urology Skills

Crowne Plaza, Newcastle Stephenson Quarter
6th June 2024

The AfPP Roadshow - Exeter

University of Exeter
22nd June 2024

EBME Expo

Coventry Building Society Arena
26th - 27th June 2024

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025